false0001140859 0001140859 2020-03-05 2020-03-05

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

_________________________________


FORM 8-K
_________________________________

CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 5, 2020
  _________________________________
AmerisourceBergen Corporation
(Exact name of registrant as specified in its charter)
_________________________________
Commission File Number: 1-6671
Delaware
 
23-3079390
(State or other jurisdiction of
 
(I.R.S. Employer
incorporation or organization)
 
Identification No.)
 
 
 
 
 
1300 Morris Drive
Chesterbrook,
PA
 
19087-5594
(Address of principal executive offices)
 
(Zip Code)
(610) 727-7000
(Registrant’s telephone number, including area code) 
Not Applicable
(Former name or former address, if changed since last report.)
 Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of exchange on which registered
Common stock
ABC
New York Stock Exchange
(NYSE)
_________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company   

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
 
 





Item 5.07. Submission of Matters to a Vote of Security Holders.

(a)     The Company held its 2020 Annual Meeting of Stockholders (the "2020 Annual Meeting") on March 5, 2020.

(b)    Each of the five items listed below was submitted to a vote of the Company's stockholders at the 2020 Annual Meeting and is described in more detail in the definitive proxy statement filed by the Company with the Securities and Exchange Commission on January 24, 2020 (the "Definitive Proxy Statement").  The final voting results are below:

Item 1 - Election of Directors.

Each of the individuals listed below was elected by the Company's stockholders to serve as a director until the 2021 annual meeting of stockholders and until his or her successor is duly elected and qualified.
Nominees
 
For
 
Against
 
Abstentions
 
Broker Non-Votes
 
Ornella Barra
 
175,515,019
 
4,631,277
 
157,026
 
11,288,046
 
Steven H. Collis
 
170,606,516
 
9,118,618
 
578,188
 
11,288,046
 
D. Mark Durcan
 
179,842,980
 
313,691
 
146,651
 
11,288,046
 
Richard W. Gochnauer
 
175,196,214
 
4,933,502
 
173,606
 
11,288,046
 
Lon R. Greenberg
 
179,679,352
 
476,339
 
147,631
 
11,288,046
 
Jane E. Henney, M.D.
 
171,241,347
 
8,910,415
 
151,560
 
11,288,046
 
Kathleen W. Hyle
 
179,617,270
 
529,579
 
156,473
 
11,288,046
 
Michael J. Long
 
165,763,361
 
14,385,707
 
154,254
 
11,288,046
 
Henry W. McGee
 
171,701,593
 
8,440,871
 
160,858
 
11,288,046
 
Dennis M. Nally
 
179,896,872
 
258,951
 
147,499
 
11,288,046
 

Item 2- Ratification of Appointment of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for Fiscal Year 2020.

The Company's stockholders approved this item.  The voting results are as follows:
For
 
Against
 
Abstentions
 
 
 
184,687,448
 
6,802,088
 
101,832
 
 
 

Item 3 - Advisory Vote to Approve the Compensation of the Company's Named Executive Officers.

The Company's stockholders approved this item.  The voting results are as follows:
For
 
Against
 
Abstentions
 
Broker Non-Votes
 
170,608,974
 
9,516,495
 
177,853
 
11,288,046
 

Item 4 - Stockholder Proposal to Permit Action by Written Consent of the Stockholders.

The Company's stockholders did not approve this item. The voting results are as follows:
For
 
Against
 
Abstentions
 
Broker Non-Votes
 
62,358,616
 
117,691,617
 
253,089
 
11,288,046
 

Item 5 - Stockholder Proposal Regarding the Use of a Deferral Period for Certain Compensation of Senior Executives.

The Company's stockholders did not approve this item. The voting results are as follows:
For
 
Against
 
Abstentions
 
Broker Non-Votes
 
61,197,092
 
114,468,371
 
4,637,859
 
11,288,046
 

No item other than the five items addressed above and described in the Definitive Proxy Statement was submitted at the 2020 Annual Meeting for stockholder action.





 SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
AMERISOURCEBERGEN CORPORATION
 
 
 
 
Date: 
March 9, 2020
By:
/s/ John G. Chou
 
 
Name:
John G. Chou
 
 
Title:
Executive Vice President, Chief Legal Officer and Secretary

 




AmerisourceBergen (NYSE:ABC)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more AmerisourceBergen Charts.
AmerisourceBergen (NYSE:ABC)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more AmerisourceBergen Charts.